Login / Signup

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis.

Tomoko MizakiHironobu NobataShogo BannoMakoto YamaguchiHiroshi KinashiShiho IwagaitsuTakuji IshimotoYukiko KuruMasafumi OhnishiKen-Ichi SakoYasuhiko Ito
Published in: Journal of pharmaceutical health care and sciences (2023)
The present study developed the first PPK model of MPA for Japanese lupus nephritis patients. As for LSSs, a double sampling strategy at 1 and 4 h by multiple linear regression would work best; when only a single blood sampling is allowed, a strategy at 6 h by Bayesian estimation using the PPK model developed in this study would be best. The LSSs good enough for clinical use may facilitate safer, more effective, and individualized therapy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • stem cells
  • peritoneal dialysis
  • bone marrow
  • mesenchymal stem cells
  • replacement therapy